Health Catalyst, Inc. — Director's Dealing 2021

Dec 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-12-27

Reporting Person: Hinton Bryan Richard (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-27	Common Stock	M	260.00	$10.80	Acquired	9635.00	Direct
2021-12-27	Common Stock	S	260.00	$39.56	Disposed	9375.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-27	Stock Option (Right to Buy)	$10.80	M	260.00	Disposed	2028-09-27	Common Stock (260.00)	Direct

Footnotes

F1: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1.

F2: 25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.